SEC Comment Letter 0000000000-24-010220 to GeoVax Labs, Inc. (GOVX)

GeoVax Labs, Inc.
Date: Sept. 10, 2024 · CIK: 0000832489 · Accession: 0000000000-24-010220

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-281972

Date

September 10, 2024

Author

David Dodd

Form

UPLOAD

Company

GeoVax Labs, Inc.

Letter

September 10, 2024 David Dodd Chief Executive Officer GeoVax Labs, Inc. 1900 Lake Park Drive, Suite 380 Smyrna, GA 30080 Re:GeoVax Labs, Inc. Registration Statement on Form S-1 Filed September 6, 2024 File No. 333-281972 Dear David Dodd: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:F. Reid Avett, Esq.

Show Raw Text

September 10, 2024
David Dodd
Chief Executive Officer
GeoVax Labs, Inc.
1900 Lake Park Drive, Suite 380
Smyrna, GA 30080
Re:GeoVax Labs, Inc.
Registration Statement on Form S-1
Filed September 6, 2024
File No. 333-281972
Dear David Dodd:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:F. Reid Avett, Esq.

SecProbe.io